FDMT — 4D MOLECULAR THERAPEUTICS IN
什么是 13F 持仓报告?谁需要申报、何时申报 · 13F 持仓报告看不到什么
最后更新: 2026-11-14 · 来源: SEC EDGAR Form 13F-HR
截至Q2 2026,共 167 家机构在其最新 13F 申报中持有 FDMT(4D MOLECULAR THERAPEUTICS IN),合计申报市值 $749.57M,对应 56.45M 股。按股数计算较上季度增持 6.2%(+2.50M 股),申报市值环比上升 51.7%。持仓集中度较高:前五大持有人占申报市值的 40.5%,前十大的集中度为 61.8%。
与上一季度相比,33 家新建仓位、65 家加仓、38 家减仓、23 家清仓退出。13F 数据为季末快照,以上变动反映的是 Q2 2026 末的持仓状态,并非实时交易。
4D MOLECULAR THERAPEUTICS IN(FDMT)的主要机构持有人包括 Jupiter Topco LLC、BlackRock Inc、RA CAPITAL MANAGEMENT, L.P.,按 13F 申报市值在本页 340 家持有人中排名居前。
FDMT 属于Health Care板块。
本页所有数据均来自美国证监会(SEC)13F 季度申报。13F 申报人需在季度结束后 45 天内披露 10 万美元以上的多头持仓;空头、期权对冲与季度内交易不在其列,因此这些数字反映的是机构持仓的季度快照,而非实时仓位。
机构逐季持仓趋势
| 季度 | 持有机构数 | 股数 | 金额 | 环比净变动 |
|---|---|---|---|---|
| Q3 2026 | 110 | 19.06M | $272.79M | +3.2% |
| Q2 2026 | 167 | 56.45M | $749.57M | +6.2% |
| Q1 2026 | 157 | 48.88M | $454.24M | -4.5% |
| Q4 2025 | 160 | 53.90M | $404.90M | +20.5% |
| Q3 2025 | 138 | 41.01M | $358.11M | -1.6% |
| Q2 2025 | 123 | 40.88M | $152.67M | -4.9% |
| Q1 2025 | 128 | 44.53M | $145.46M | +1.9% |
| Q4 2024 | 141 | 47.58M | $265.63M | -15.6% |
表内 8 个季度中,机构持股合计减少 60%(Q4 2024 → Q3 2026);单季变动最大的是 Q4 2025(+20.5%)。
前 25 大机构持仓人(Q3 2026) — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 4.72M | $67.61M | 0.00% | 增持 | |
| 2.47M | $35.34M | 0.00% | 减持 | |
| 2.14M | $30.63M | 0.00% | 增持 | |
| 1.18M | $16.95M | 0.00% | 增持 | |
| 1.09M | $15.61M | 0.00% | 增持 | |
| 787.00K | $11.26M | 0.00% | 增持 | |
| 578.93K | $8.28M | 0.00% | 持有 | |
| 546.09K | $7.81M | 0.00% | 减持 | |
| 411.79K | $5.89M | 0.01% | 减持 | |
| 393.03K | $5.69M | 0.00% | 减持 | |
| 390.87K | $5.59M | 0.00% | 减持 | |
| 311.94K | $4.46M | 0.00% | 增持 | |
| 305.93K | $4.38M | 0.01% | 新进 | |
| 300.72K | $4.30M | 0.00% | 增持 | |
| 260.12K | $3.72M | 0.00% | 增持 | |
| 241.86K | $3.46M | 0.00% | 持有 | |
| 179.87K | $2.57M | 0.00% | 增持 | |
| 179.15K | $2.56M | 1.36% | 减持 | |
| 176.68K | $2.53M | 0.00% | 减持 | |
| 152.58K | $2.18M | 0.00% | 持有 | |
| 146.19K | $2.09M | 0.04% | 持有 | |
| 127.97K | $1.83M | 0.00% | 增持 | |
| 118.13K | $1.69M | 0.00% | 减持 | |
| 106.95K | $1.53M | 0.57% | 减持 | |
| 105.00K | $1.50M | 0.32% | 新进 |
更早季度的机构持仓记录(逐季列表): 返回前 25 大机构持仓人
Q2 2026 — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 5.75M | $76.47M | 0.03% | 新进 | |
| 5.05M | $67.16M | 0.58% | 持有 | |
| 4.55M | $60.46M | 0.00% | 增持 | |
| 4.26M | $56.64M | 0.02% | 增持 | |
| 3.25M | $43.21M | 2.51% | 减持 | |
| 2.88M | $38.29M | 0.98% | 持有 | |
| 2.51M | $33.41M | 0.02% | 新进 | |
| 2.25M | $29.91M | 0.04% | 增持 | |
| 2.23M | $29.63M | 4.70% | 增持 | |
| 2.10M | $27.92M | 0.00% | 新进 | |
| 2.00M | $26.60M | 0.35% | 持有 | |
| 1.13M | $15.01M | 0.00% | 新进 | |
| 1.13M | $15.01M | 0.00% | 增持 | |
| 1.12M | $14.90M | 0.00% | 增持 | |
| 951.47K | $12.65M | 0.20% | 持有 | |
| 948.18K | $12.61M | 1.29% | 增持 | |
| 730.86K | $9.72M | 0.00% | 增持 | |
| 710.94K | $9.46M | 0.00% | 持有 | |
| 614.57K | $8.17M | 0.01% | 增持 | |
| 579.90K | $7.71M | 0.00% | 增持 | |
| 571.11K | $7.60M | 1.65% | 新进 | |
| 562.93K | $7.49M | 0.00% | 增持 | |
| 507.80K | $6.75M | 4.71% | 增持 | |
| 503.07K | $6.69M | 0.00% | 减持 | |
| 503.02K | $6.69M | 0.00% | 增持 |
Q1 2026 — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 5.25M | $48.87M | 0.02% | 增持 | |
| 5.05M | $47.01M | 0.50% | 减持 | |
| 4.21M | $39.15M | 0.01% | 减持 | |
| 4.15M | $38.59M | 0.00% | 增持 | |
| 3.65M | $33.99M | 2.75% | 持有 | |
| 2.88M | $26.81M | 0.85% | 减持 | |
| 2.71M | $25.21M | 0.00% | 增持 | |
| 2.00M | $18.62M | 0.37% | 增持 | |
| 1.61M | $14.94M | 0.02% | 增持 | |
| 1.43M | $13.33M | 0.02% | 减持 | |
| 1.30M | $12.13M | 2.95% | 新进 | |
| 1.07M | $9.92M | 0.00% | 增持 | |
| 974.17K | $9.07M | 0.00% | 增持 | |
| 951.47K | $8.86M | 0.20% | 持有 | |
| 708.04K | $6.59M | 0.00% | 增持 | |
| 578.26K | $5.38M | 0.01% | 增持 | |
| 561.80K | $5.23M | 0.00% | 增持 | |
| 555.83K | $5.17M | 0.00% | 新进 | |
| 522.58K | $4.87M | 0.50% | 增持 | |
| 522.82K | $4.86M | 0.00% | 增持 | |
| 475.74K | $4.43M | 0.04% | 持有 | |
| 380.42K | $3.58M | 2.26% | 新进 | |
| 415.65K | $3.56M | 0.00% | 增持 | |
| 345.41K | $3.22M | 0.00% | 减持 | |
| 342.03K | $3.18M | 0.00% | 增持 |
Q4 2025 — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 5.65M | $42.40M | 0.43% | 增持 | |
| 4.64M | $34.73M | 0.02% | 增持 | |
| 4.63M | $34.72M | 1.17% | 持有 | |
| 4.30M | $32.27M | 0.01% | 增持 | |
| 4.06M | $30.49M | 0.00% | 增持 | |
| 3.65M | $27.38M | 2.13% | 增持 | |
| 3.09M | $23.20M | 0.00% | 增持 | |
| 2.69M | $20.17M | 0.00% | 增持 | |
| 1.94M | $14.52M | 0.18% | 增持 | |
| 1.61M | $12.07M | 0.02% | 增持 | |
| 1.54M | $11.55M | 0.04% | 新进 | |
| 1.24M | $9.26M | 0.01% | 增持 | |
| 1.01M | $7.59M | 0.00% | 增持 | |
| 951.47K | $7.14M | 0.14% | 新进 | |
| 832.59K | $6.24M | 0.00% | 增持 | |
| 704.21K | $5.28M | 0.00% | 增持 | |
| 672.70K | $5.05M | 0.00% | 减持 | |
| 512.90K | $3.85M | 0.01% | 增持 | |
| 503.43K | $3.78M | 0.36% | 增持 | |
| 485.39K | $3.64M | 0.08% | 减持 | |
| 477.50K | $3.58M | 0.00% | 增持 | |
| 475.74K | $3.57M | 0.02% | 新进 | |
| 475.74K | $3.57M | 0.04% | 新进 | |
| 353.39K | $2.65M | 0.00% | 增持 | |
| 353.39K | $2.65M | 0.00% | 增持 |
Q3 2025 — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 4.63M | $40.23M | 1.63% | 持有 | |
| 4.56M | $39.65M | 0.49% | 持有 | |
| 4.13M | $35.88M | 0.01% | 减持 | |
| 3.87M | $33.62M | 0.00% | 减持 | |
| 2.58M | $22.38M | 0.00% | 减持 | |
| 2.00M | $17.38M | 1.12% | 持有 | |
| 1.75M | $15.24M | 0.01% | 持有 | |
| 1.59M | $13.86M | 0.02% | 减持 | |
| 1.15M | $9.99M | 0.02% | 减持 | |
| 1.15M | $9.99M | 0.00% | 减持 | |
| 1.10M | $9.52M | 0.14% | 增持 | |
| 913.52K | $7.94M | 0.00% | 减持 | |
| 903.77K | $7.85M | 0.00% | 减持 | |
| 835.91K | $7.26M | 0.00% | 减持 | |
| 819.27K | $7.12M | 0.00% | 增持 | |
| 663.66K | $5.77M | 0.01% | 增持 | |
| 549.70K | $4.78M | 0.01% | 减持 | |
| 543.33K | $4.72M | 0.00% | 增持 | |
| 513.51K | $4.46M | 0.00% | 减持 | |
| 504.12K | $4.38M | 0.08% | 减持 | |
| 471.27K | $4.10M | 0.00% | 增持 | |
| 335.59K | $2.92M | 0.00% | 增持 | |
| 322.08K | $2.80M | 2.50% | 增持 | |
| 313.19K | $2.72M | 0.00% | 增持 | |
| 305.86K | $2.66M | 0.00% | 增持 |
Q2 2025 — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 4.63M | $17.17M | 0.61% | 增持 | |
| 4.56M | $16.93M | 0.28% | 持有 | |
| 4.16M | $15.43M | 0.01% | 持有 | |
| 4.01M | $14.88M | 0.00% | 减持 | |
| 2.74M | $10.15M | 0.00% | 减持 | |
| 2.00M | $7.42M | 0.52% | 增持 | |
| 1.75M | $6.51M | 0.00% | 减持 | |
| 1.67M | $6.19M | 0.01% | 增持 | |
| 1.48M | $5.50M | 0.01% | 减持 | |
| 1.48M | $5.50M | 0.00% | 减持 | |
| 961.96K | $3.57M | 0.00% | 减持 | |
| 924.68K | $3.43M | 0.00% | 减持 | |
| 918.53K | $3.41M | 0.00% | 减持 | |
| 888.02K | $3.29M | 0.00% | 持有 | |
| 743.40K | $2.76M | 0.01% | 增持 | |
| 648.83K | $2.41M | 0.01% | 持有 | |
| 531.16K | $1.97M | 0.00% | 增持 | |
| 514.61K | $1.91M | 0.03% | 减持 | |
| 455.47K | $1.69M | 0.00% | 增持 | |
| 328.98K | $1.22M | 0.00% | 减持 | |
| 318.54K | $1.18M | 1.18% | 增持 | |
| 30.00K | $1.17M | 0.00% | 持有 | |
| 300.00K | $1.11M | 0.02% | 持有 | |
| 295.04K | $1.09M | 0.00% | 增持 | |
| 295.04K | $1.09M | 0.00% | 增持 |
新建仓(Q2 2026)
- Jupiter Topco LLC 5.75M 股 · $76.47M
- T. Rowe Price Investment Management, Inc. 2.51M 股 · $33.41M
- VANGUARD CAPITAL MANAGEMENT LLC 2.10M 股 · $27.92M
- GEODE CAPITAL MANAGEMENT, LLC 1.13M 股 · $15.01M
- DIADEMA PARTNERS LP 571.11K 股 · $7.60M
- Catalio Capital Management, LP 471.25K 股 · $6.27M
- Sixth Street Partners Management Company, L.P. 339.27K 股 · $4.51M
- Brevan Howard Capital Management LP 176.85K 股 · $2.35M
- Persistent Asset Partners Ltd 145.59K 股 · $1.94M
- Greenland Capital Management LP 72.26K 股 · $961.02K
- Caption Management, LLC 70.00K 股 · $931.00K
- SG Americas Securities, LLC 66.44K 股 · $884.00K
完全清仓(较上季)
- Janus Henderson Group 卖出 5.25M 股 · $48.87M
- STATE STREET CORP 卖出 2.71M 股 · $25.21M
- Peapod Lane Capital LLC 卖出 241.48K 股 · $2.21M
- Exome Asset Management LLC 卖出 130.56K 股 · $1.22M
- ADAR1 Capital Management, LLC 卖出 116.71K 股 · $1.09M
- Simplify Asset Management Inc. 卖出 70.43K 股 · $655.70K
- Principia Wealth Advisory, LLC 卖出 53.67K 股 · $499.65K
- Quadrature Capital Ltd 卖出 32.52K 股 · $302.80K
- Virtu Financial LLC 卖出 26.37K 股 · $245.00K
- Y-Intercept (Hong Kong) Ltd 卖出 25.42K 股 · $236.66K
- EntryPoint Capital, LLC 卖出 21.60K 股 · $201.12K
- ExodusPoint Capital Management, LP 卖出 15.53K 股 · $144.57K
基金持仓历史 — 各季度股数(前 20 只基金)
| 基金 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BlackRock Inc | 4.72M | 4.55M | 4.15M | 4.06M | 3.87M | 4.01M | 4.55M | 4.92M | 4.87M | — | — | — | — | — | — | — | — | — | — | — |
| STATE STREET CORP | 2.47M | — | 2.71M | 2.69M | 903.77K | 961.96K | 1.03M | 1.11M | 2.12M | 2.08M | 2.18M | 1.52M | 1.72M | — | — | — | — | — | — | — |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.14M | 2.10M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Geode Capital Management | 1.18M | 1.13M | 1.07M | 1.01M | 913.52K | 918.53K | 963.27K | 1.01M | 1.04M | 1.06M | 872.66K | 778.16K | 741.66K | 689.78K | 577.92K | 561.74K | 528.94K | 492.82K | 478.62K | 482.44K |
| Morgan Stanley | 1.09M | 503.02K | 345.41K | 672.70K | 835.91K | 924.68K | 1.78M | 1.86M | 1.70M | 1.46M | 1.55M | 1.57M | 1.47M | 1.57M | 1.74M | 1.46M | 2.02M | 313.04K | 420.04K | 434.08K |
| DIMENSIONAL FUND ADVISORS LP | 787.00K | 730.86K | 522.82K | 294.84K | 58.01K | 55.94K | 74.57K | 131.97K | 208.81K | 532.74K | 748.99K | 694.89K | 670.60K | — | — | — | — | — | — | — |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 578.93K | 579.90K | 555.83K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Deutsche Bank AG | 546.09K | 710.94K | 708.04K | 704.21K | 543.33K | 226.94K | 236.16K | 241.85K | 802.64K | 124.34K | 121.86K | 486.99K | 15.57K | 676.15K | 80.27K | 74.97K | 73.32K | 13.29K | 15.52K | 17.28K |
| Renaissance Technologies | 411.79K | 614.57K | 578.26K | 512.90K | 313.19K | 116.55K | 19.55K | — | — | — | 69.83K | — | — | — | 13.80K | 128.10K | 69.10K | 259.60K | 69.10K | 44.80K |
| JPMorgan Chase & Co | 393.03K | 402.14K | 415.65K | 279.50K | 513.51K | 888.02K | 886.71K | 820.07K | 315.98K | 345.77K | 16.60K | 3.80K | 585.45K | 457.21K | 417.32K | 439.97K | 453.11K | 478.76K | 367.55K | 283.39K |
| Nuveen, LLC | 390.87K | 503.07K | 561.80K | 158.77K | 93.92K | 100.70K | 150.31K | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Fidelity Management & Research (FMR) | 311.94K | 128.32K | 70.10K | 65.65K | 65.57K | 62.07K | 7.87K | 2.04K | 4.10K | 1.02M | 968.88K | 3.64K | 2.76K | 2.83K | 2.69K | 26.90K | 288.20K | 700.45K | 1.09M | 1.14M |
| HRT FINANCIAL LP | 305.93K | — | — | — | — | 43.90K | 50.40K | 83.42K | — | — | — | 9.99K | 26.02K | — | — | — | — | — | — | — |
| VANGUARD FIDUCIARY TRUST CO | 300.72K | 276.24K | 269.30K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Invesco Ltd | 260.12K | 150.38K | 310.68K | 153.14K | 126.58K | 140.32K | 117.77K | 28.16K | 27.43K | 27.45K | 27.67K | 14.08K | 17.48K | 215.58K | — | 196.20K | 10.55K | 10.65K | 10.74K | 10.98K |
| RAYMOND JAMES FINANCIAL INC | 241.86K | 242.35K | 266.15K | 477.50K | 471.27K | 455.47K | 294.38K | 112.90K | — | — | — | — | — | — | — | — | — | — | — | — |
| BARCLAYS PLC | 179.87K | 23.82K | 25.44K | 170.64K | 93.83K | 111.78K | 97.04K | 105.25K | 114.85K | 47.65K | 47.82K | 108.71K | 73.94K | — | — | — | — | — | — | — |
| Propel Bio Management, LLC | 179.15K | 252.65K | 380.42K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| FEDERATED HERMES, INC. | 176.68K | 222.42K | 1.43M | 1.61M | 1.59M | 1.67M | 1.25M | 3.76K | — | — | 27 | — | — | — | — | — | — | — | — | — |
| BNY Mellon | 152.58K | 152.34K | 133.61K | 136.74K | 141.72K | 141.10K | 134.85K | 145.94K | 146.41K | 169.41K | 131.40K | 144.94K | 135.71K | 116.28K | 108.45K | 109.91K | 107.22K | 97.81K | 101.32K | 100.19K |
▲ 低买(基金新建/增持,下一季股价上涨 ≥5%) ▼ 高卖(基金减持,下一季股价下跌 ≥5%)
拖拽/滚轮缩放 · 默认显示最近一年 · 标注来自 13F 申报中的季度基金操作 · 悬停查看详情
常见问题
Which funds hold FDMT?
As of 2026-Q2, 167 institutional funds reported holding FDMT (4D MOLECULAR THERAPEUTICS IN) in SEC 13F filings, with a combined reported value of $749.57M.
How many shares of FDMT do institutions own?
13F filers reported 56.45M shares of FDMT, worth $749.57M in aggregate at the end of 2026-Q2.
Is institutional ownership of FDMT rising or falling?
Share counts moved +6.2% versus the prior quarter — accumulation.
Who are the top institutional holders of FDMT?
The largest 13F holders are Jupiter Topco LLC, BlackRock Inc, RA CAPITAL MANAGEMENT, L.P., VIKING GLOBAL INVESTORS LP, Viking Global Investors; the top 25 are ranked at the top of this page.
Who are the major shareholders of 4D MOLECULAR THERAPEUTICS IN?
The major shareholders of 4D MOLECULAR THERAPEUTICS IN (FDMT) by reported 13F value are Jupiter Topco LLC, BlackRock Inc, RA CAPITAL MANAGEMENT, L.P., VIKING GLOBAL INVESTORS LP, Viking Global Investors, among 340 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.